about
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainCloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brainN-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivoSupersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseN-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipaseDelta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampusCannabis and psychosis/schizophrenia: human studiesThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinNovel endogenous peptide agonists of cannabinoid receptorsEvidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonistHeavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analysesThe orphan receptor GPR55 is a novel cannabinoid receptorCannabinoid pharmacology: the first 66 yearsMarijuana and cannabinoid regulation of brain reward circuitsAgonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorSpecies-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersEvidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptorCannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuseCannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisThe molecular connections between the cannabinoid system and endometriosisEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsRobust optimization of SVM hyperparameters in the classification of bioactive compoundsThe CB2 receptor and its role as a regulator of inflammationHuman platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptorNoladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissuesControl of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptorsExogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic reviewThe role of sex steroid hormones, cytokines and the endocannabinoid system in female fertilityThe effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performanceHU-308: a specific agonist for CB(2), a peripheral cannabinoid receptorThe endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensEnhanced acetylcholine release in the hippocampus of cannabinoid CB(1) receptor-deficient micePharmacological analysis of cannabinoid receptor activity in the rat vas deferensMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideCharacterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamideCannabinoids and the gastrointestinal tract
P2860
Q21561008-2D1B2052-4481-468C-AFB5-356CCC14A8EBQ24299523-2AEA0FEF-C435-466E-BF70-8F53A25201A3Q24532188-8B3D16A1-A826-46D9-9521-9F906245F5E9Q24555807-2E6D8613-814A-44FA-BB6D-4F48296BAE4AQ24569817-C54410A3-5639-4398-8B00-06F8F69540A4Q24597687-20A701A2-97A1-411C-926B-E276195BA66AQ24628837-42746A05-EF46-4666-A10F-D000A8D80130Q24643876-7E156C2B-454E-4DB3-AD62-CE0594004FF3Q24644673-324C1652-02A1-4AB5-90B9-7A4ABB96F4E9Q24646822-61D97163-0CC6-4AF8-ABDB-6633591A6024Q24654726-FE6B9C30-478E-46E4-95EB-D20F9B47165CQ24670137-D9A5C3E0-F0A8-400A-878E-50499839F4FAQ24670395-A4166777-8407-4A1F-84AB-51CBCCE2117AQ24671514-96ACF79E-70F4-44AF-8114-1E982088B6EBQ24672356-B1606B3A-845F-4C4F-B5AA-7B9D0B9E4700Q24672600-1A408244-8B0A-4495-A3AB-245922C9BDB5Q24673335-D229B9EF-CBF5-48C0-817A-BBCEF2510D23Q24676188-21F4323A-C479-4D02-8C92-93BE0D5C24D7Q24680848-245054B5-54F1-4D2F-98BF-4D56E0BF4E31Q24685807-11A563BD-A917-4309-8B84-8865456744D1Q26783956-74FE7722-D80C-4948-84B3-B8C361F7AC2BQ27005719-4E768DBA-13EC-4825-ADD4-683491215D50Q27009220-8A6A1ACB-3A29-4F91-91BA-7E8DD8C6BB9EQ27009466-96F72148-C276-4699-97E7-BC5176D5D200Q27902297-96B1E29A-5585-40AD-8EC3-AA04FA20611CQ28066700-08AA16C6-5950-4E94-B624-389CE3F08813Q28175607-DFB052EF-319F-4E53-A5D7-6C417EB12CCBQ28208218-FC68D77A-7ABF-4E9A-AE4E-0F416061CEEDQ28270337-10116C28-7F31-4B9F-BF2E-D2EBB26A3E27Q28300877-6D519570-31C2-4D78-AF8E-332157BCC385Q28303095-E4FC4D96-D0F9-4A0C-98D4-C4CEA182862BQ28303831-B5CF45C0-9D8D-43C8-9D7A-96EBA1C67109Q28343769-689D2A0E-0649-4C00-9468-D5BF8E4E8294Q28343961-715E313C-CB2F-4426-9C75-2BAE375E3608Q28346456-83BB6E10-E794-4920-8699-D462BDC1F3DAQ28360131-67A855B7-D255-4F4D-BBF3-453D8F2808D5Q28360193-A47CD0AC-A8D4-41A1-8CC5-EA138F3FDCCAQ28362078-70977403-A1B2-4DBF-AA5D-1B72A368EAB0Q28363051-8DFAE36B-99A1-4D86-89D5-4988DED37C33Q28365382-5462B887-F5C5-44CE-9938-3A2D82B37F5C
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Pharmacology of cannabinoid CB1 and CB2 receptors.
@ast
Pharmacology of cannabinoid CB1 and CB2 receptors.
@en
Pharmacology of cannabinoid CB1 and CB2 receptors.
@nl
type
label
Pharmacology of cannabinoid CB1 and CB2 receptors.
@ast
Pharmacology of cannabinoid CB1 and CB2 receptors.
@en
Pharmacology of cannabinoid CB1 and CB2 receptors.
@nl
prefLabel
Pharmacology of cannabinoid CB1 and CB2 receptors.
@ast
Pharmacology of cannabinoid CB1 and CB2 receptors.
@en
Pharmacology of cannabinoid CB1 and CB2 receptors.
@nl
P921
P1476
Pharmacology of cannabinoid CB1 and CB2 receptors
@en
P2093
Pertwee RG
P304
P356
10.1016/S0163-7258(97)82001-3
P577
1997-01-01T00:00:00Z